Delivery Order SPE2DB20D3103-SPE2DB22FM0Z8

Award Date 12/27/21
Potential Completion Date 12/28/21
Potential Value $13K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,266.24 firm fixed-price delivery order is for the supply of Topamax 25 mg sprinkle capsules. The contract has an ultimate completion date of June 10, 2022 and was awarded on June 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Topamax 15 mg sprinkle capsules. The one-year $1,311.58 firm fixed-price delivery order, awarded on August 25, 2021, supports the DLA Troop Support Medical program. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,280.38 firm fixed price delivery order is for the supply of Topamax 15 mg sprinkle capsules. The contract has a completion date of June 5, 2024 and was awarded on June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Topamax 25 mg sprinkle capsules, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a potential value of $1,767.72 and a completion date of January 30, 2024. No set-aside designation was...
This federal contract award is a delivery order valued at $1,219.24 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TOPAMAX 25 MG SPRINKLE CAP 60S, a prescription medication, with an ultimate completion date of December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,268,333 units of Topamax 25 mg sprinkle capsules in 60-count packages. The $6,350.61 Firm Fixed Price contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $6,111.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product Topamax 25 mg sprinkle capsules. The award has an ultimate completion date of January 3, 2024 and is a firm fixed-price contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,767.72 firm fixed-price delivery order is for the supply of 60 units of the medication Topamax 25 mg sprinkle capsules. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of...
This federal contract award, valued at $3,537.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Topamax 25 mg sprinkle capsules, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award, identified as SPE2DB20D1004|SPE2DB21FF8Z1, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,934.26, is for the delivery of the pharmaceutical product Topamax 15 mg sprinkle capsules. The contract is a delivery order, with a firm fixed price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FM0Z8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Topamax 25 mg sprinkle capsules. The contract, valued at $13,153.35, is a Firm Fixed Price Delivery Order with a completion date of December 28, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This contract is part of DLA's broader efforts to efficiently procure essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:51 AM